Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Bellicum Pharmaceuticals Inc (BLCM)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Endurant Capital Management

Vishal Saluja And Pham Quang

144,300 $947 0.35%
2.
Baker Bros. Advisors

Julian Baker And Felix Baker

4,151,578 $27,234 -18% 0.23%
3.
Dorset Management

David M. Knott

67,653 $444 +13% 0.18%
4.
Ascend Capital

Malcolm Fairbairn

400,994 $2,630 0.1%
5.
Ellington

Mike Vranos

58,200 $382 +121% 0.02%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$12.00 151,177 Large Shareholder 4,527,089 2017-03-24 Filing
$12.00 15,489 Large Shareholder 434,760 2017-03-24 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$7.97 6,206 Officer 26,548 2018-05-25 Filing
$7.91 4,136 Large Shareholder 58,131 2018-01-19 Filing
$7.91 265,708 Large Shareholder 3,734,776 2018-01-19 Filing
$7.91 25,517 Large Shareholder 358,671 2018-01-19 Filing
$8.12 4,548 Large Shareholder 62,267 2018-01-18 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 70,814 $464 0.48%
2. 106,050 $696 0.43%
3. 75,722 $497 0.3%
4. 350,000 $2,296 0.24%
5. 205,255 $1,835 0.07%
News See All